Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Cardinal Health

Cardinal Health Sees Relative Strength Rating Climb To 74

Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Is Cardinal Health Stock Underperforming the Dow?

Cardinal Health has underperformed the Dow Jones Industrial Average over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

Stocks With Rising Relative Strength: Cardinal Health

Cardinal Health shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on Cardinal Health Stock?

Although Cardinal Health has underperformed relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Cardinal Health Stock Sees IBD RS Rating Improve To 71

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Investors Business Daily

What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

Barchart

Is Cardinal Health Stock Underperforming the Nasdaq?

Despite Cardinal Health’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Another troubled drugstore chain files for Chapter 11 bankruptcy

The operator of a pharmacy chain has filed for Chapter 11 bankruptcy.

The Street

Cardinal Health Stock Sees Relative Strength Rating Climb To 71

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Investors Business Daily

Cardinal Health Clears Buy Point On Bullish Fiscal 2025 View

Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations

Investors Business Daily

Stock Index Futures Tread Water as Key U.S. Inflation Data Looms

September S&P 500 E-Mini futures (ESU24) are up +0.02%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.09% this morning as market participants held back from making any big bets ahead of the release of the U.S. consumer inflation report.

Barchart

Are Wall Street Analysts Bullish on Cardinal Health Stock?

Cardinal Health has underperformed the broader market over the past year, but Wall Street analysts are moderately bullish about the stock’s prospects.

Barchart

Health Care Giant McKesson Dives Amid Big Revenue Miss

McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates.

Investors Business Daily

Here's What to Expect From Cardinal Health's Next Earnings Report

Cardinal Health is all set to announce its fourth-quarter results next month, and analysts are projecting double-digit earnings growth.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court

Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.

Barchart

What Are Wall Street Analysts' Target Price for Cardinal Health Stock?

Cardinal Health’s shares have underperformed the broader market over the past year, yet Wall Street analysts maintain a cautiously optimistic outlook on the stock.

Barchart

Stocks Settle Higher on Q1 Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.02%. US stock indexes settled moderately higher on Monday, with the Dow Jones Industrials posting...

Investors Business Daily

Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses

The S&P 500 rebounded Monday, led by Ford, United Airlines and megacap AI stock Nvidia. Verizon and Tesla were notable losers.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks Soar with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) is up +1.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.53%. US stock indexes today are surging higher. Reduced geopolitical tensions are positive for stocks after...

Barchart

Stocks Mixed with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.04%. US stock indexes today are mixed. Reduced geopolitical tensions are positive for stocks...

Investors Business Daily

Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Barchart

3 Healthcare Stocks Ready to Soar in 2024

Unlock the gates of wellness with these breakout healthcare stocks.

StockNews.com

3 Medical Marvel Stocks to Buy for Success

The medical sector is thriving, given the growing healthcare expenditure and rapid technological adoption. Given the industry’s tailwinds, fundamentally sound medical stocks Cardinal Health (CAH), Fresenius (FSNUY), and Zynex (ZYXI) could be ideal buys for substantial returns. Keep Reading….

Barchart

3 Dividend Aristocrats Beating the Market in 2023

Here's a look at three standout Dividend Aristocrats that not only offer stable income for yield hunters, but are delivering better returns than the broad market so far in 2023 - with more upside expected over the next year.

Investors Business Daily

Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand

Cardinal Health and Cencora both broke out after topping earnings estimates as both drug-distributors got a boost from GLP-1 weight-loss drugs.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Chipotle Mexican Grill

154 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.